Ceprotin Treatment Registry
Latest Information Update: 18 Mar 2021
At a glance
- Drugs Protein C (Primary) ; Protein C
- Indications Protein C deficiency
- Focus Adverse reactions; Registrational
- Sponsors Baxalta; Baxter Healthcare Corporation
- 10 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 14 Dec 2014 Planned primary completion date changed from 1 Jul 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov record
- 12 Dec 2014 Planned End Date changed from 1 Sep 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov record.